First-in-Class Lupus Drug Aces Phase III Test

(MedPage Today) — BARCELONA — A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control, according to phase III trial data…

Source link : https://www.medpagetoday.com/meetingcoverage/eular/116036

Author :

Publish date : 2025-06-12 16:13:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

First-in-Class Lupus Drug Aces Phase III Test

Four science-based rules that will make your conversations flow

I’m an ACIP Liaison. This Public Health Purge Was Baseless.

Related Posts

Study Reveals Link Between Junk Food and Lung Cancer Risk

Kamchatka earthquake response shows tsunami warnings are improving

FDA Slaps Stronger Warnings on Opioids

Google Reviews for Patients; MD Reacts to Sydney Sweeney Ad; Dangers of Starvation

How to Make Healthcare Affordable? Senators’ Suggestions Vary Widely

U.S. Childhood Vaccination Rates Fall Again as Exemptions Set Another Record

Study Reveals Link Between Junk Food and Lung Cancer Risk

Kamchatka earthquake response shows tsunami warnings are improving

FDA Slaps Stronger Warnings on Opioids

Google Reviews for Patients; MD Reacts to Sydney Sweeney Ad; Dangers of Starvation

How to Make Healthcare Affordable? Senators’ Suggestions Vary Widely

U.S. Childhood Vaccination Rates Fall Again as Exemptions Set Another Record

Here’s Why Kids Get More Vaccines Today Than in the 1980s

Cutting Medicaid Funding Isn’t the Only Worrisome Change to the Program

Categories

Archives